About Bene Ekine-Afolabi Bene Ekine-Afolabi
Inventor, Cancer Immunology Expert, Medical Microbiologist, Toxicologist, Environment & Climate Advocate & Harvard Alumnae Network leader.
Dr. Bene Ekine II‑Afolabi leads high‑impact research into colorectal cancer therapeutics, boards climate and health organizations, and empowers women in science globally through advisory roles and advocacy.
Scientific Innovation & Therapeutic Discovery
Dr. Bene Ekine II‑Afolabi PhD has dedicated her career to understanding molecular mechanisms of colorectal cancer, applying rigorous immunology and toxicology research, and moving findings toward clinically relevant therapies. Her work at ZEAB Therapeutic includes ADME studies ‑ in vitro and in vivo ‑ and patent development in collaboration with global institutions.
Advocacy, Environment, & Global Leadership
Serving in leadership roles such as Vice President of Ijaw Diaspora Council‑Europe, Board Trustee of CIWI & ECHE, and active member of Harvard Business Review Advisory Council, Dr. Bene Ekine II‑Afolabi leverages science to shape policy. As a Climate Reality Project Leader and environmental advocate, she brings focus to how environmental toxins and climate change influence health.
Education, Mentorship & Community Impact
From teaching at Middlesex University to supervising BSc/MSc students and supporting patient advocacy, Dr. Bene Ekine II‑Afolabi fosters scientific literacy and inclusion. She is especially dedicated to supporting women in STEM, leading Harvard Alumnae‑i Network initiatives, and mentoring young researchers across Africa and the diaspora.